Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 9/24/19 → 8/18/21 |
Funding
- Parexel International LLC: $131,725.00
MG0003: A Phase 3, Randomized, Double-Blind, Placebo Controlled Study Evaluating Efficacy and Safety of Rozanolixzumab in Adult Patients with Generalized Myasthenia Gravis
- Mahuwala, Zabeen (PI)